First Midwest Bank Trust Division lowered its stake in UnitedHealth Group Inc. (NYSE:UNH) by 8.1% during the second quarter, Holdings Channel reports. The firm owned 29,065 shares of the healthcare conglomerate’s stock after selling 2,573 shares during the period. First Midwest Bank Trust Division’s holdings in UnitedHealth Group were worth $4,104,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in UNH. MCF Advisors LLC increased its stake in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock valued at $123,000 after buying an additional 726 shares during the period. Benjamin F. Edwards & Company Inc. increased its stake in shares of UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares during the last quarter. Evanson Asset Management LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth approximately $201,000. Parametrica Management Ltd purchased a new stake in shares of UnitedHealth Group during the second quarter worth approximately $201,000. Finally, Franklin Street Advisors Inc. NC purchased a new stake in shares of UnitedHealth Group during the second quarter worth approximately $208,000. Institutional investors and hedge funds own 85.78% of the company’s stock.
UnitedHealth Group Inc. (NYSE:UNH) traded up 1.21% during trading on Friday, hitting $140.00. 4,164,080 shares of the company traded hands. UnitedHealth Group Inc. has a one year low of $107.51 and a one year high of $144.48. The firm has a market cap of $133.33 billion, a P/E ratio of 21.91 and a beta of 0.57. The firm has a 50 day moving average of $138.43 and a 200 day moving average of $135.92.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The company earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. On average, analysts expect that UnitedHealth Group Inc. will post $7.90 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were paid a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio is 39.12%.
A number of brokerages recently commented on UNH. Evercore ISI began coverage on shares of UnitedHealth Group in a research report on Thursday, September 22nd. They issued a “buy” rating and a $155.00 price objective for the company. Cowen and Company set a $150.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Tuesday, September 6th. Sanford C. Bernstein restated an “outperform” rating and issued a $178.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, September 6th. Jefferies Group restated a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, August 23rd. Finally, Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research report on Sunday, August 21st. One analyst has rated the stock with a hold rating, twenty-four have issued a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and an average price target of $154.96.
In other news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the SEC, which is available at this link. 1.65% of the stock is currently owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.